Engineered hematopoietic stem and progenitor cells for mucopolysaccharidosis type I

By Claire Quang | Oct 24, 2019 | 5:30 PM GMT

Editor's note: Updated on Oct 29, 2019 at 5:41 PM GMT

DISEASE CATEGORY: Endocrine/Metabolic

INDICATION: Mucopolysaccharidosis

Hematopoietic stem and progenitor cells (HSPCs) engineered to overexpress IDUA could treat mucopolysaccharidosis

Read the full 165 word article

How to gain access

Continue reading with a
two-week free trial.